Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
KYMR
KYMR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KYMR News
Analysis of KYMR Options Trading Dynamics
Mar 03 2026
NASDAQ.COM
Kymera Therapeutics (KYMR.US) Insider Plans to Sell $18.27 Million in Common Stock via Form 144
Mar 02 2026
moomoo
Piper Sandler Raises Kymera Price Target to $140 on Strong Clinical Data
Feb 27 2026
Yahoo Finance
Kymera Therapeutics Highlights Q4 2025 Earnings Call
Feb 26 2026
seekingalpha
Kymera Therapeutics Set to Announce Q4 Earnings
Feb 25 2026
seekingalpha
Baker Bros. Advisors Increases Stake in Kymera Therapeutics
Feb 23 2026
Fool
Baker Bros. Advisors Increases Stake in Kymera Therapeutics
Feb 23 2026
Yahoo Finance
Rock Springs Capital Increases Stake in Kymera Therapeutics
Feb 17 2026
Fool
Kymera Stock Soars as Secretive Hedge Fund Acquires $172 Million Stake.
Dec 14 2025
Barron's
S&P 500 Futures Decline in Pre-Market Session; Fermi and Broadcom Underperform
Dec 12 2025
Barron's
Kymera Receives FDA Fast Track Designation for KT-621, Aiming to Transform Atopic Dermatitis Treatment
Dec 11 2025
Globenewswire
Kymera Receives FDA Fast Track Designation for KT-621, Aiming to Improve Atopic Dermatitis Treatment
Dec 11 2025
Newsfilter
Kymera's oral candidate KT-621 for eczema receives Fast Track designation.
Dec 11 2025
SeekingAlpha
Kymera Therapeutics Prices $602 Million Public Offering of Common Stock
Dec 10 2025
Globenewswire
Kymera Therapeutics Prices $602 Million Public Offering of Common Stock
Dec 10 2025
Newsfilter
Broadcom Set for Approximately 10% Surge? Check Out 10 Leading Analyst Predictions for Tuesday
Dec 09 2025
Benzinga
Show More News
